KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeMD (LFMD) Debt to Equity (2016 - 2025)

LifeMD's Debt to Equity history spans 6 years, with the latest figure at $5.31 for Q2 2025.

  • For Q2 2025, Debt to Equity rose 258.5% year-over-year to $5.31; the TTM value through Jun 2025 reached $5.31, up 258.5%, while the annual FY2024 figure was -$1.12, N/A changed from the prior year.
  • Debt to Equity reached $5.31 in Q2 2025 per LFMD's latest filing, up from -$0.05 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $5.31 in Q2 2025 to a low of -$3.35 in Q2 2024.
  • Average Debt to Equity over 3 years is -$0.04, with a median of -$0.81 recorded in 2021.
  • The largest YoY upside for Debt to Equity was 258.5% in 2025 against a maximum downside of 102.98% in 2025.
  • A 3-year view of Debt to Equity shows it stood at -$0.58 in 2021, then crashed by 92.78% to -$1.12 in 2024, then skyrocketed by 574.72% to $5.31 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Debt to Equity are $5.31 (Q2 2025), -$0.05 (Q1 2025), and -$1.12 (Q4 2024).